Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of FOLOFOXIRI plus Cetuximab combination in young
patients with good performance status with unresectable metastatic colorectal cancer.